SEARCH

SEARCH BY CITATION

REFERENCES

  • American Psychiatric Association. 2004. Practice guidelines for the treatment of patients with schizophrenia. Washington DC: American Psychiatric.
  • Barnett JH, Jones PB, Robbins TW, Muller U. 2007. Effects of the catechol-O-methyltransferase Val158Met polymorphism on executive function: A meta-analysis of the Wisconsin Card Sort Test in schizophrenia and healthy controls. Mol Psychiatry 12(5): 502509.
  • Beuten J, Payne TJ, Ma JZ, Li MD. 2006. Significant association of catechol-O-methyltransferase (COMT) haplotypes with nicotine dependence in male and female smokers of two ethnic populations. Neuropsychopharmacology 31(3): 675684.
  • Chen CY, Lu RB, Yeh YW, Shih MC, Huang SY. 2011. Association study of catechol-O-methyltransferase gene polymorphisms with schizophrenia and psychopathological symptoms in Han Chinese. Genes Brain Behav 10(3): 316324.
  • Chen X, Wang X, O'Neill AF, Walsh D, Kendler KS. 2004. Variants in the catechol-o-methyltransferase (COMT) gene are associated with schizophrenia in Irish high-density families. Mol Psychiatry 9(10): 962967.
  • Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR. 2001. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 98(12): 69176922.
  • Fan JB, Zhang CS, Gu NF, Li XW, Sun WW, Wang HY, Feng GY, St Clair D, He L. 2005. Catechol-O-methyltransferase gene Val/Met functional polymorphism and risk of schizophrenia: A large-scale association study plus meta-analysis. Biol Psychiatry 57(2): 139144.
  • Fanous AH, Kendler KS. 2005. Genetic heterogeneity, modifier genes, and quantitative phenotypes in psychiatric illness: Searching for a framework. Mol Psychiatry 10(1): 613.
  • Gauderman WJ. 2002. Sample size requirements for association studies of gene-gene interaction. Am J Epidemiol 155(5): 478484.
  • Handoko HY, Nyholt DR, Hayward NK, Nertney DA, Hannah DE, Windus LC, McCormack CM, Smith HJ, Filippich C, James MR, et al. 2005. Separate and interacting effects within the catechol-O-methyltransferase (COMT) are associated with schizophrenia. Mol Psychiatry 10(6): 589597.
  • Hoenicka J, Garrido E, Martinez I, Ponce G, Aragues M, Rodriguez-Jimenez R, Espana-Serrano L, Alvira-Botero X, Santos JL, Rubio G, et al. 2010. Gender-specific COMT Val158Met polymorphism association in Spanish schizophrenic patients. Am J Med Genet Part B Neuropsychiatr Genet 153B(1): 7985.
  • Inada T, Nakamura A, Iijima Y. 2003. Relationship between catechol-O-methyltransferase polymorphism and treatment-resistant schizophrenia. Am J Med Genet Part B Neuropsychiatr Genet 120B(1): 3539.
  • Ittiwut R, Listman JB, Ittiwut C, Cubells JF, Weiss RD, Brady K, Oslin D, Farrer LA, Kranzler HR, Gelernter J. 2011. Association between polymorphisms in catechol-O-methyltransferase (COMT) and cocaine-induced paranoia in European-American and African-American populations. Am J Med Genet Part B Neuropsychiatr Genet 156B(6): 651660.
  • Kapur S. 2004. How antipsychotics become anti-“psychotic”–from dopamine to salience to psychosis. Trends Pharmacol Sci 25(8): 402406.
  • Koen L, Kinnear CJ, Corfield VA, Emsley RA, Jordaan E, Keyter N, Moolman-Smook JC, Stein DJ, Niehaus DJ. 2004. Violence in male patients with schizophrenia: Risk markers in a South African population. Aust N Z J Psychiatry 38(4): 254259.
  • Molero P, Ortuno F, Zalacain M, Patino-Garcia A. 2007. Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: Influence on the severity of psychotic symptoms and on the response to neuroleptic treatment. Pharmacogenomics J 7(6): 418426.
  • Munafo MR, Bowes L, Clark TG, Flint J. 2005. Lack of association of the COMT (Val158/108 Met) gene and schizophrenia: A meta-analysis of case-control studies. Mol Psychiatry 10(8): 765770.
  • Nackley AG, Shabalina SA, Tchivileva IE, Satterfield K, Korchynskyi O, Makarov SS, Maixner W, Diatchenko L. 2006. Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science 314(5807): 19301933.
  • Okochi T, Ikeda M, Kishi T, Kawashima K, Kinoshita Y, Kitajima T, Yamanouchi Y, Tomita M, Inada T, Ozaki N, et al. 2009. Meta-analysis of association between genetic variants in COMT and schizophrenia: An update. Schizophr Res 110(1–3): 140148.
  • Owen MJ. 2005. Genomic approaches to schizophrenia. Clin Ther 27( Suppl A): S2S7.
  • Pelayo-Teran JM, Crespo-Facorro B, Carrasco-Marin E, Perez-Iglesias R, Mata I, Arranz MJ, Leyva-Cobian F, Vazquez-Barquero JL. 2008. Catechol-O-methyltransferase Val158Met polymorphism and clinical characteristics in first episode non-affective psychosis. Am J Med Genet Part B Neuropsychiatr Genet 147B(5): 550556.
  • Pelayo-Teran JM, Perez-Iglesias R, Vazquez-Bourgon J, Mata I, Carrasco-Marin E, Vazquez-Barquero JL, Crespo-Facorro B. 2011. Catechol-O-methyltransferase Val158Met polymorphism and negative symptoms after acute antipsychotic treatment in first-episode non-affective psychosis. Psychiatry Res 185(1–2): 286289.
  • Pulver AE, Karayiorgou M, Lasseter VK, Wolyniec P, Kasch L, Antonarakis S, Housman D, Kazazian HH, Meyers D, Nestadt G, et al. 1994. Follow-up of a report of a potential linkage for schizophrenia on chromosome 22q12-q13.1: Part 2. Am J Med Genet 54(1): 4450.
  • Roussos P, Giakoumaki SG, Pavlakis S, Bitsios P. 2008. Planning, decision-making and the COMT rs4818 polymorphism in healthy males. Neuropsychologia 46(2): 757763.
  • Sagud M, Muck-Seler D, Mihaljevic-Peles A, Vuksan-Cusa B, Zivkovic M, Jakovljevic M, Pivac N. 2010. Catechol-O-methyl transferase and schizophrenia. Psychiatr Danub 22(2): 270274.
  • Sazci A, Ergul E, Kucukali I, Kilic G, Kaya G, Kara I. 2004. Catechol-O-methyltransferase gene Val108/158Met polymorphism, and susceptibility to schizophrenia: Association is more significant in women. Brain Res Mol Brain Res 132(1): 5156.
  • Shield AJ, Thomae BA, Eckloff BW, Wieben ED, Weinshilboum RM. 2004. Human catechol O-methyltransferase genetic variation: Gene resequencing and functional characterization of variant allozymes. Mol Psychiatry 9(2): 151160.
  • Shifman S, Bronstein M, Sternfeld M, Pisante-Shalom A, Lev-Lehman E, Weizman A, Reznik I, Spivak B, Grisaru N, Karp L, et al. 2002. A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet 71(6): 12961302.
  • Stefanis NC, Van Os J, Avramopoulos D, Smyrnis N, Evdokimidis I, Hantoumi I, Stefanis CN. 2004. Variation in catechol-o-methyltransferase val158 met genotype associated with schizotypy but not cognition: A population study in 543 young men. Biol Psychiatry 56(7): 510515.
  • Strous RD, Lapidus R, Viglin D, Kotler M, Lachman HM. 2006. Analysis of an association between the COMT polymorphism and clinical symptomatology in schizophrenia. Neurosci Lett 393(2–3): 170173.
  • Tao R, Wei J, Guo Y, Yu Y, Xu Q, Shi J, Liu S, Ju G, Li Y, Shen Y. 2006. The PLA2G4A gene and negative symptoms in a Chinese population. Schizophr Res 86(1–3): 326328.
  • Tsai SJ, Hong CJ, Liao DL, Lai IC, Liou YJ. 2004. Association study of a functional catechol-O-methyltransferase genetic polymorphism with age of onset, cognitive function, symptomatology and prognosis in chronic schizophrenia. Neuropsychobiology 49(4): 196200.
  • Wang Y, Fang Y, Shen Y, Xu Q. 2010. Analysis of association between the catechol-O-methyltransferase (COMT) gene and negative symptoms in chronic schizophrenia. Psychiatry Res 179(2): 147150.
  • Woods SW. 2003. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 64(6): 663667.
  • Yeh YW, Lu RB, Tao PL, Shih MC, Lin WW, Huang SY. 2010. Neither single-marker nor haplotype analyses support an association between the dopamine transporter gene and heroin dependence in Han Chinese. Genes Brain Behav 9(6): 638647.
  • Yu R, Zhang XN, Huang XX, Ding SP, Li JC. 2007. Association analysis of COMT polymorphisms and schizophrenia in a Chinese Han population: A case-control study. Am J Med Genet Part B Neuropsychiatr Genet 144B(4): 570573.